Crystal structure of haloxon, C14H14Cl3O6P

被引:0
|
作者
Kaduk, James A. [1 ,2 ]
Gates-Rector, Stacy [3 ]
Blanton, Thomas N. [3 ]
机构
[1] IIT, 3101 S Dearborn St, Chicago, IL 60616 USA
[2] North Cent Coll, 131 S Loomis St, Naperville, IL 60540 USA
[3] ICDD, 12 Campus Blvd, Newtown Sq, PA 19073 USA
关键词
haloxon; Galloxon; powder diffraction; Rietveld refinement; density functional theory; DENSITY;
D O I
10.1017/S0885715622000422
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
The crystal structure of haloxon has been solved and refined using synchrotron X-ray powder diffraction data, and optimized using density functional theory techniques. Haloxon crystallizes in space group P2(1)/n (#14) with a = 19.60382(6), b = 10.05473(3), c = 8.73591(2) angstrom, beta = 92.6617(2)degrees, V = 1720.088(11) angstrom(3), and Z = 4. The structure consists of discrete molecules. The mean planes of the fused ring systems are approximately 0-11 and 011. The rings form staggered stacks perpendicular to these planes. There are no traditional hydrogen bonds in the structure, but several C-HMIDLINE HORIZONTAL ELLIPSISO and C-HMIDLINE HORIZONTAL ELLIPSISCl hydrogen bonds contribute to the crystal energy. The powder pattern has been submitted to ICDD for inclusion in the Powder Diffraction File (TM) (PDF (R)).
引用
收藏
页码:235 / 239
页数:5
相关论文
共 50 条
  • [1] Crystal structure of ponazuril, C18H14F3N3O6S
    Kaduk, James A.
    Gates-Rector, Stacy
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2022, 37 (04) : 225 - 229
  • [2] Crystal structure of imepitoin, C13H14ClN3O2
    Kaduk, James A.
    Gindhart, Amy M.
    Gates-Rector, Stacy
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2022, 37 (04) : 206 - 210
  • [3] Crystal structure of vismodegib, C19H14Cl2N2O3S
    Kaduk, James A.
    Gates-Rector, Stacy
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2023, 38 (01) : 1 - 6
  • [4] Crystal structure of deracoxib, C17H14F3N3O3S
    Kaduk, James A.
    Gindhart, Amy M.
    Gates-Rector, Stacy
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2023, 38 (01) : 64 - 68
  • [5] Crystal structure of choline fenofibrate (Trilipix®), (C5H14NO) (C17H14ClO4)
    Kaduk, James A.
    Zhong, Kai
    Gindhart, Amy M.
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2016, 31 (02) : 142 - 148
  • [6] Crystal structure of rivastigmine hydrogen tartrate Form I (Exelon®), C14H23N2O2(C4H5O6)
    Kaduk, James A.
    Zhong, Kai
    Gindhart, Amy M.
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2016, 31 (02) : 97 - 103
  • [7] Crystal structure of besifloxacin hydrochloride, C19H22ClFN3O3Cl
    Kaduk, James A.
    Gates-Rector, Stacy
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2023, 38 (01) : 43 - 52
  • [8] Crystal structure of diclazuril, C17H9Cl3N4O2
    Kaduk, James A.
    Gates-Rector, Stacy
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2022, 37 (04) : 230 - 234
  • [9] Crystal structure of pantoprazole sodium sesquihydrate Form I, C16H14F2N3O4SNa(H2O)1.5
    Gonzalez, Diana
    Golab, Joseph T.
    Kaduk, James A.
    Gindhart, Amy M.
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2020, 35 (01) : 53 - 60
  • [10] Crystal structures of cefdinir, C14H13N5O5S2, and cefdinir sesquihydrate C14H13N5O5S2(H2O)1.5
    Wheatley, Austin M.
    Kaduk, James A.
    Gindhart, Amy M.
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2019, 34 (03) : 267 - 278